FGFR1OP2 anticorps (AA 51-150) (Biotin)

N° du produit ABIN1398547

Détail du produit anti-FGFR1OP2 anticorps (Biotin)

Antigène: FGFR1OP2 (FGFR1 Oncogene Partner 2 (FGFR1OP2))

Épitope: AA 51-150

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp FGFR1OP2 est conjugé à/à la Biotin

Application: ELISA, Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Homologie: Human,Mouse,Rat,Dog,Horse,Rabbit

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human FGFR1OP2

Isotype: IgG

Information d'application

Indications d'application: WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C for 12 months.

Date de péremption: 12 months

Détails sur FGFR1OP2

Antigène: FGFR1OP2 (FGFR1 Oncogene Partner 2 (FGFR1OP2))

Autre désignation: FGFR1OP2 (FGFR1OP2 Produits)

Synonymes: anticorps FGFR1OP2, anticorps MGC143105, anticorps DKFZp459I1618, anticorps HSPC123-like, anticorps WIT3.0, anticorps 1500031J01Rik, anticorps Wit3.0, anticorps wu:fj17h04, anticorps zgc:64126, anticorps FGFR1 oncogene partner 2, anticorps FGFR1 oncogene partner 2 S homeolog, anticorps FGFR1OP2, anticorps fgfr1op2, anticorps Fgfr1op2, anticorps fgfr1op2.S

Sujet:

Synonyms: DKFZp564O1863, FGFR1 oncogene partner 2, HSPC123, HSPC123 like, FGOP2_HUMAN.

Background: FGFR1OP2 belongs to the SIKE family. The FGFR1OP2 (FGFR1 oncogene partner 2) gene was identified through its involvement in a fusion with the FGFR1 gene. FGFR1OP2 may be involved in the wound healing pathway. It is expressed in bone marrow, spleen and thymus. A chromosomal aberration involving FGFR1OP2 may be a cause of stem cell myeloproliferative disorder (MPD). Insertion ins(12,8)(p11,p11p22) with FGFR1. MPD is characterized by myeloid hyperplasia, eosinophilia and T cell or B cell lymphoblastic lymphoma. In general it progresses to acute myeloid leukemia. The fusion protein FGFR1OP2-FGFR1 may exhibit constitutive kinase activity and be responsible for the transforming activity.

ID gène: 26127